Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Read more
An active recall has been issued for a liquid multivitamin supplement sold across 24 states and territories due to contamination concerns, federal regulators announced.
The U.S. Food and Drug Administration classified the action as a Class II recall Tuesday over concerns it may contain a “black particulate matter” or “foreign object”.
A Class II classification indicates that consuming the affected product could cause temporary or medically reversible adverse health consequences.
The recall from Miami-based Llorens Pharmaceuticals International Division, Inc. affects more than 4,000 units of Nephronex multivitamin supplement, an 8-fluid-ounce liquid formula containing vitamin B-complex, vitamin C and folic acid.
According to a consumer alert from the California State Board of Pharmacy, the affected bottles feature the lot code “B2025” and an expiration date of “08/27.”
More than 4,000 units of Nephronex liquid multivitamin are included in the active recall. The affected 8-fluid-ounce bottles contain vitamin B-complex, vitamin C and folic acid (Getty Images)
The Independent has reached out to Llorens Pharmaceuticals for comment.
Regulators stated the product was sold between February 2026 and May 2026 in Arizona, California, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Puerto Rico, Tennessee, Texas, Virginia, Washington, West Virginia and Wisconsin.
Health officials advise consumers who have the matching product on hand to stop using it immediately. The items should either be discarded or returned to the place of purchase for a refund. Individuals experiencing health concerns after taking the supplement are urged to seek medical attention.
Consumers seeking additional details regarding the recall can contact the FDA directly at 1-888-463-6332.